Volume | 8,666,111 |
|
|||||
News | - | ||||||
Day High | 7.34 | Low High |
|||||
Day Low | 6.93 |
Etf Name | Etf Symbol | Market | Stock Type |
---|---|---|---|
Advisorshares Pure Us Cannabis Etf | MSOS | AMEX | Exchange Traded Fund |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
7.20 | 6.93 | 7.34 | 6.99 | 7.23 |
Trades | Etfs Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
20,211 | 8,666,111 | 7.13 | 61,783,260 | - | 4.78 - 11.365 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
19:00:00 | 275,222 | 6.99 | USD |
Advisorshares Pure Us Ca... (MSOS) Options Flow Summary
Advisorshares Pure Us Cannabis Etf Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
825.98M | - | - | - | 12.38 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News Advisorshares Pure Us Ca...
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
MSOS Historical
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 7.63 | 7.93 | 6.93 | 7.57 | 6,847,874 | -0.57 | -7.47% |
1 Month | 9.97 | 9.97 | 6.93 | 8.15 | 8,304,413 | -2.91 | -29.19% |
3 Months | 9.68 | 11.365 | 6.93 | 9.28 | 10,559,088 | -2.62 | -27.07% |
6 Months | 6.51 | 11.365 | 5.99 | 8.97 | 8,616,951 | 0.55 | 8.45% |
1 Year | 5.33 | 11.365 | 4.78 | 8.12 | 7,231,340 | 1.73 | 32.46% |
3 Years | 40.32 | 41.3888 | 4.78 | 10.26 | 3,462,026 | -33.26 | -82.49% |
5 Years | 24.90 | 55.91 | 4.78 | 11.71 | 2,868,516 | -17.84 | -71.65% |
The investment seeks long-term capital appreciation. The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology and life sciences industry group within the health care sector. The fund is non-diversified. |